Adult cochlear implant candidacy criteria

A cochlear implant bypasses a damaged cochlea entirely, delivering electrical stimulation directly to the auditory nerve, so candidacy is built around showing that hearing aids, which only amplify sound for whatever cochlear function remains, are not doing enough. The core requirement for an adult candidate is a sensorineural hearing loss in the moderate to profound range, generally worse in the higher frequencies, combined with limited speech understanding even when well-fitted, appropriately verified hearing aids are being worn.

That second requirement, poor performance despite optimal amplification, is usually demonstrated with an aided speech recognition test, most often sentence recognition in quiet or in noise, scored in the ear or ears being considered for implantation. Candidates typically show aided sentence or word recognition scores at or below a threshold in roughly the 40 to 60 percent range, though the exact cutoff, the specific test used, and whether it is measured in quiet or in noise differ across FDA-cleared devices and across clinics.

When cochlear implants were first approved, FDA labeling restricted them to adults with profound bilateral sensorineural hearing loss and essentially no benefit from hearing aids. Over successive labeling updates, the criteria have broadened considerably: candidacy now extends to adults with moderate to severe loss in the low frequencies paired with severe to profound loss in the high frequencies, a pattern sometimes described as sloping or ski-slope loss, and to single-sided deafness in some current device labeling. The overall direction of change has been to include less severe hearing loss and better preoperative hearing than earlier labeling allowed, on the strength of outcome data showing that patients with more residual hearing still benefit meaningfully from implantation.

Because FDA labeling differs somewhat between manufacturers and is revised periodically, the exact pure-tone and word-recognition thresholds that define candidacy for a given device should be checked against that device's current labeling rather than assumed from an earlier version. This is an area where practice has moved faster than any single textbook table can stay current.

Three different things can all reasonably be called candidacy criteria, and they do not always agree with each other. FDA labeling defines the minimum population a device is approved to treat. A clinic's own candidacy protocol may be somewhat more conservative or somewhat more permissive than the labeling, based on that program's clinical judgment and experience. An insurer's coverage policy, which decides whether the surgery will actually be paid for, can be stricter than either the labeling or the clinic's protocol, and coverage policies vary by payer.

For that reason, describing candidacy only in terms of a single fixed audiometric cutoff or a single word-recognition percentage overstates how settled the boundary actually is. The safer, and more accurate, description is the general pattern: moderate to profound sensorineural loss, limited benefit from well-fitted and properly verified hearing aids, and a preoperative workup, including imaging and medical evaluation, confirming there is no contraindication to implantation.